| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Eptifibatide acetate | 881997-86-0 | sc-205675 sc-205675A sc-205675B | 5 mg 10 mg 50 mg | $51.00 $109.00 $257.00 | 5 | |
Eptifibatide acetate functions as a potent antagonist of integrin alpha IIb, disrupting the fibrinogen binding necessary for platelet aggregation. Its unique structure allows for high specificity in binding, effectively blocking the conformational changes required for integrin activation. This inhibition alters the dynamics of platelet signaling pathways, impacting cellular adhesion and migration. The compound's interaction with integrins showcases its role in modulating cellular responses through competitive inhibition. | ||||||
E7820 | 289483-69-8 | sc-507333 | 10 mg | $102.00 | ||
GR 144053 trihydrochloride | 1215333-48-4 | sc-361192 sc-361192A | 10 mg 50 mg | $116.00 $660.00 | 3 | |
GR 144053 trihydrochloride acts as a selective modulator of integrin alpha IIb, influencing the molecular interactions that govern platelet function. Its unique binding affinity alters the conformational landscape of integrin complexes, thereby affecting downstream signaling cascades. The compound's kinetic profile reveals a rapid onset of action, with distinct competitive binding characteristics that modify cellular adhesion dynamics. This specificity highlights its role in fine-tuning integrin-mediated processes. | ||||||
Cilengitide | 188968-51-6 | sc-507335 | 5 mg | $215.00 | ||
Tirofiban-d6 | 144494-65-5 (unlabeled) | sc-475655 | 1 mg | $450.00 | ||
Reversible antagonist of αIIbβ3, inhibiting platelet aggregation. | ||||||
Picotamide | 32828-81-2 | sc-201334 sc-201334A | 10 mg 50 mg | $92.00 $366.00 | 1 | |
Inhibits thromboxane A2 formation and αIIbβ3 activation. | ||||||